Diamyd Medical marks World Diabetes Day with expert panel on the future of Type 1 Diabetes treatment
On the World Diabetes Day, Diamyd Medical will host a live moderated discussion featuring leading experts in Type 1 Diabetes research and advocacy. The session will explore how advances in immune tolerance and precision medicine are driving the transition from symptom management to true disease modification in type 1 diabetes. The panel includes: · Professor Johnny Ludvigsson, Linköping University · Professor Åke Lernmark, Lund University · Joshua Vieth, Senior Director, Breakthrough T1D, US · Ulf Hannelius, CEO, Diamyd Medical, Stockholm “World Diabetes Day is an